This exploratory study examined proteomic changes in serum and nasal fluid in patients with aspirin-exacerbated respiratory disease (AERD) undergoing high-dose aspirin therapy, assessing how the proteome shifts with treatment.
Exploratory design limits generalizability; no specific sample size or comparator group details are provided in the available metadata; results may not be validated in an independent cohort.
